Angela S Watkins, John H Kempen, Dongseok Choi, Teresa L Liesegang, S S Pujari, Craig Newcomb, Robert B Nussenblatt, James T Rosenbaum, Jennifer E Thorne, C Stephen Foster, Douglas A Jabs, Grace A Levy-Clarke, Eric B Suhler, Justine R Smith
{"title":"anca阳性血管炎患者的眼部疾病。","authors":"Angela S Watkins, John H Kempen, Dongseok Choi, Teresa L Liesegang, S S Pujari, Craig Newcomb, Robert B Nussenblatt, James T Rosenbaum, Jennifer E Thorne, C Stephen Foster, Douglas A Jabs, Grace A Levy-Clarke, Eric B Suhler, Justine R Smith","doi":"10.1007/s12177-009-9044-4","DOIUrl":null,"url":null,"abstract":"<p><p>Anti-neutrophil cytoplasmic antibody (ANCA)-positive vasculitis-the term recently applied to Wegener's granulomatosis-is a rare multi-system inflammation characterized by necrotizing granulomas and vasculitis. We investigated the ocular manifestations of this disease in a group of patients drawn from five inflammatory eye disease clinics across the United States. Of 8,562 persons with ocular inflammation, 59 individuals were diagnosed with ANCA-positive vasculitis; 35 males and 21 females, aged 16 to 96 years, were included in this study. Ocular diagnoses were scleritis (75.0%), uveitis (17.9%), and other ocular inflammatory conditions (33.9%) including peripheral ulcerative keratitis and orbital pseudotumor. Mean duration of ocular disease was 4.6 years. Oral corticosteroids and other systemic immunosuppressive agents were used by 85.7% and 78.5% of patients, respectively. Over time, patients with ANCA-positive vasculitis experienced 2.75-fold higher mortality than other patients with inflammatory eye disease.</p>","PeriodicalId":73873,"journal":{"name":"Journal of ocular biology, diseases, and informatics","volume":"3 1","pages":"12-19"},"PeriodicalIF":0.0000,"publicationDate":"2009-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s12177-009-9044-4","citationCount":"57","resultStr":"{\"title\":\"Ocular disease in patients with ANCA-positive vasculitis.\",\"authors\":\"Angela S Watkins, John H Kempen, Dongseok Choi, Teresa L Liesegang, S S Pujari, Craig Newcomb, Robert B Nussenblatt, James T Rosenbaum, Jennifer E Thorne, C Stephen Foster, Douglas A Jabs, Grace A Levy-Clarke, Eric B Suhler, Justine R Smith\",\"doi\":\"10.1007/s12177-009-9044-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Anti-neutrophil cytoplasmic antibody (ANCA)-positive vasculitis-the term recently applied to Wegener's granulomatosis-is a rare multi-system inflammation characterized by necrotizing granulomas and vasculitis. We investigated the ocular manifestations of this disease in a group of patients drawn from five inflammatory eye disease clinics across the United States. Of 8,562 persons with ocular inflammation, 59 individuals were diagnosed with ANCA-positive vasculitis; 35 males and 21 females, aged 16 to 96 years, were included in this study. Ocular diagnoses were scleritis (75.0%), uveitis (17.9%), and other ocular inflammatory conditions (33.9%) including peripheral ulcerative keratitis and orbital pseudotumor. Mean duration of ocular disease was 4.6 years. Oral corticosteroids and other systemic immunosuppressive agents were used by 85.7% and 78.5% of patients, respectively. Over time, patients with ANCA-positive vasculitis experienced 2.75-fold higher mortality than other patients with inflammatory eye disease.</p>\",\"PeriodicalId\":73873,\"journal\":{\"name\":\"Journal of ocular biology, diseases, and informatics\",\"volume\":\"3 1\",\"pages\":\"12-19\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2009-12-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1007/s12177-009-9044-4\",\"citationCount\":\"57\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of ocular biology, diseases, and informatics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s12177-009-9044-4\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of ocular biology, diseases, and informatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12177-009-9044-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Ocular disease in patients with ANCA-positive vasculitis.
Anti-neutrophil cytoplasmic antibody (ANCA)-positive vasculitis-the term recently applied to Wegener's granulomatosis-is a rare multi-system inflammation characterized by necrotizing granulomas and vasculitis. We investigated the ocular manifestations of this disease in a group of patients drawn from five inflammatory eye disease clinics across the United States. Of 8,562 persons with ocular inflammation, 59 individuals were diagnosed with ANCA-positive vasculitis; 35 males and 21 females, aged 16 to 96 years, were included in this study. Ocular diagnoses were scleritis (75.0%), uveitis (17.9%), and other ocular inflammatory conditions (33.9%) including peripheral ulcerative keratitis and orbital pseudotumor. Mean duration of ocular disease was 4.6 years. Oral corticosteroids and other systemic immunosuppressive agents were used by 85.7% and 78.5% of patients, respectively. Over time, patients with ANCA-positive vasculitis experienced 2.75-fold higher mortality than other patients with inflammatory eye disease.